Bernhard Hemmerlein

4.5k citations

90 papers · 3.1k indexed · 1 hit paper · h-index 29

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
Genetics top 5%

Papers in

Cancer Research 21
- Protease and Inhibitor Mechanisms 6
Oncology 26
- Peptidase Inhibition and Analysis 8

Co-authors: Paul Thelen Karl H. Plate A. Eberhard Valentin Goede Hellmut G. Augustin Stefan Schweyer Peter Burfeind Michal A. Rahat
Journals: International Journal of Oncology (7 papers)The Journal of Urology (5 papers)Histopathology (3 papers)The Journal of Pathology (3 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Bernhard Hemmerlein

89 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. 2000 · 610 citations

Peers

Countries citing papers authored by Bernhard Hemmerlein

Since Specialization

Citations

This map shows the geographic impact of Bernhard Hemmerlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Hemmerlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Hemmerlein more than expected).

Fields of papers citing papers by Bernhard Hemmerlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Hemmerlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Hemmerlein. The network helps show where Bernhard Hemmerlein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bernhard Hemmerlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernhard Hemmerlein Line = papers co-authored together Bernhard Hemmerlein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Is CCL2 an Important Mediator of Mast Cell–Tumor Cell Interactions in Oral Squamous Cell Carcinoma? International Journal of Molecular Sciences ·Bernhard Hemmerlein, F. L’hote, Zeynab Sobhani, BEN P KIRTMAN, Henning Schliephake, Phillipp Brockmeyer	2023	5
2	High mast cell density indicates a longer overall survival in oral squamous cell carcinoma Scientific Reports ·Phillipp Brockmeyer, Alexander Kling, В. М. Снегирев, Christina Perske, Henning Schliephake, Bernhard Hemmerlein	2017	15
3	Connexin subtype expression during oral carcinogenesis: A pilot study in patients with oral squamous cell carcinoma Molecular and Clinical Oncology ·Phillipp Brockmeyer, Bernhard Hemmerlein, Klaus Jung, Werner Hiltner, MA Ford, Rudolf Gruber, Henning Schliephake, Franz‐Josef Kramer	2015	5
4	Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Daniel J. Brody, Felix Bremmer, Bernhard Hemmerlein, Arne Strauß, Philipp Ströbel, Heinz‐Joachim Radzun	2013	43
5	Macrophage-tumor cell interactions regulate the function of nitric oxide Frontiers in Physiology ·Michal A. Rahat, Bernhard Hemmerlein	2013	85
6	Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells International Journal of Oncology ·Micah Israel, Carsten Gründker, Kojima Ryoichi, Mehmet Barış Daryal, Ludwig Wilkens, Michael D. Mueller, Bernhard Hemmerlein, Günter Emons, Andreas R. Günthert	2012	30
7	Das primäre pulmonale Plasmozytom: Kasuistik eines seltenen Lungentumors DMW - Deutsche Medizinische Wochenschrift ·Караулов, Qinhong Zheng, Dagmar Haase, Bernhard Hemmerlein, B. Wörmann	2008	1
8	Entwicklung eines „Preplanning-Computermodells“ zur Radiofrequenzablation von Nierentumoren Der Urologe ·Bastián Aballay, Kyriacos Felekkis, Bernhard Hemmerlein, Johanna C Escher, Guy De Vel, Dirk Dahlhaus, Rachel Hall, Peter Albers	2007	1
9	Overexpression of Eag1 potassium channels in clinical tumours Molecular Cancer ·Bernhard Hemmerlein, 鄭銀圭, Fernanda Mello de Queiroz, Gaëlle Dussin, Araceli Sánchez, María E. Rubio, Sabine Martin, T J Flavin, Shai Erev Levi, Chi Zhou, Walter Stühmer, Luis A. Pardo	2006	216
10	Expression and functional analysis of Bax inhibitor‐1 in human breast cancer cells The Journal of Pathology ·Michal Grzmil, Silke Kaulfuß, Paul Thelen, Bernhard Hemmerlein, Stefan Schweyer, Silvia Obenauer, Nengsih Nengsih, Peter Burfeind	2005	55
11	Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo Thrombosis and Haemostasis ·Hans‐Ulrich Pauer, Thomas Renné, Bernhard Hemmerlein, Tobias J. Legler, Wupeng Yan, Ibrahim M. Adham, Werner Müller‐Esterl, Guenter Emons, U. Sancken, Wolfgang Engel, Peter Burfeind	2004	103
12	Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma Oncogene ·Roland Kappler, Karima Wardani Dwika, Julia Calzada‐Wack, Michael Rosemann, Bernhard Hemmerlein, Heidi Hahn	2004	27
13	Expression of matrix metalloproteinases MMP‐2, MMP‐9 and their tissue inhibitors TIMP‐1, ‐2, and ‐3 in benign and malignant tumours of the salivary gland Histopathology ·Philippe Ducas, Rainer Laskawi, Anke Wahlers, Bernhard Hemmerlein	2004	56
14	Bax Inhibitor-1 Is Overexpressed in Prostate Cancer and Its Specific Down-Regulation by RNA Interference Leads to Cell Death in Human Prostate Carcinoma Cells American Journal Of Pathology ·Michal Grzmil, Paul Thelen, Bernhard Hemmerlein, Stefan Schweyer, Tan Loc Le, Marilyn K. Martin, Peter Burfeind	2003	72
15	The relative number of macrophages/microglia expressing macrophage colony‐stimulating factor and its receptor decreases in multiple sclerosis lesions Glia ·Yunjoo Kim, Andreas Bitsch, Stephanie Bunkowski, Bernhard Hemmerlein, Wolfgang Brück	2002	22
16	QUANTIFICATION AND IN SITU LOCALIZATION OF MCP-1mRNA AND ITS RELATION TO THE IMMUNE RESPONSE OF RENAL CELL CARCINOMA Cytokine ·Bernhard Hemmerlein, Ferdinand T. Snellen, A. Kugler, IULIIA SAMOILYK, Heinz‐Joachim Radzun	2001	12
17	Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas Cancer Immunology Immunotherapy ·Bernhard Hemmerlein, 中村守正, Aleksey V. Postnikov, A. Kugler, (unknown), (unknown)	2000	26
18	In situ Detection of Human Monocyte/ Macrophage Serine Esterase-1 mRNA Expression in Human Tissues Pathobiology ·Toshifumi Satoh, Bernhard Hemmerlein, J. Fasel, H. J. Radzun	1999	12
19	The Value of Anti-Calretinin Antibody in the Differential Diagnosis of Normal and Reactive Mesothelia versus Metastatic Tumors in Effusion Cytology Pathology - Research and Practice ·Holger Nagel, Bernhard Hemmerlein, I Ruschenburg, Juan Croquevielle R., M Droese	1998	36
20	Treosulfan shows cytotoxic effect on spheroids from primary cell cultures of kidney cell carcinomas independently of P-glycoprotein expression Der Urologe ·A. Kugler, Bernhard Hemmerlein, Andreas J. Gross, F. Seseke, M. Kallerhoff, R.‐H. Ringert	1998	1

About Bernhard Hemmerlein

Bernhard Hemmerlein is a scholar working on Cancer Research, Oncology, Genetics, Gastroenterology and Immunology and Allergy, having authored 90 papers that have together received 3.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Renal cell carcinoma treatment (7 papers), Protease and Inhibitor Mechanisms (6 papers), Immune cells in cancer (6 papers), Eosinophilic Esophagitis (5 papers), Hedgehog Signaling Pathway Studies (5 papers), Molecular Biology Techniques and Applications (5 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Cancer Research (635 citations), Genetics (273 citations), Molecular Biology (1.7k citations), Oncology (629 citations) and Immunology and Allergy (138 citations). Bernhard Hemmerlein has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Paul Thelen, Karl H. Plate, A. Eberhard, Valentin Goede, Hellmut G. Augustin, Stefan Schweyer, Peter Burfeind, Michal A. Rahat, Michal Grzmil and A. Kugler. Their work appears in journals such as International Journal of Oncology, The Journal of Urology, Histopathology, The Journal of Pathology and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact